Amid growing opposition, CVS Health awaits approval for Aetna deal

Published



Despite opposition from doctors and an increasingly complicated regulatory landscape, CVS Health reaffirmed Wednesday its intention to complete the $69 billion acquisition of insurer Aetna, for which federal approval is pending.

The American Medical Association and California’s insurance commissioner earlier this year urged the Trump administration to halt the deal. Media reports in July, however, suggested the Department of Justice would not seek to block it. In its latest earnings report, CVS said the agency is still reviewing the transaction after a second request for information in February.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.